JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 14 July 2003. doi:10.1083/jcb1622iti5
This Article
Right arrow Full Text (PDF, 793K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2003/7/167-b $5.00
The Journal of Cell Biology, Volume 162, Number 2, 167-b-167


In This Issue

Kicking out antiviral proteins



LMP1 excludes E2F4 (red) from the nucleus (arrows).

Like a bouncer at a club, the Epstein Barr virus (EBV) LMP1 protein removes a threatening presence by ejecting cellular proteins from the nucleus, according to Ohtani et al. on page 173.

EBV infection leads to excessive cell proliferation that can cause disorders such as carcinoma and lymphoma. Cells normally prevent unusual proliferation by inducing the p16INK4a/RB-dependent senescence pathway. But the authors show that EBV bypasses this failsafe by relocating transcription factors for this pathway to the cytoplasm.

Nuclear export was induced by the viral protein LMP1. EBV infection or LMP1 expression caused the export of Ets2, the inducer of p16INK4a transcription. LMP1 also kicked out transcription factors E2F4 and E2F5, which normally act downstream of p16INK4a to prevent cell cycle progression. LMP1 induces export of its targets by increasing their affinity for CRM1, which directs the major nuclear export pathway in mammalian cells. The molecular details are unclear as yet, but the authors find that the MEK pathway is required for E2F4 export. Perhaps phosphorylation of E2F4 makes it more attractive to CRM1.

Immortalization of human cells requires inactivation of both RB and p53 pathways, so LMP1 or another EBV protein may also cause the export of p53-related proteins. Ohtani et al. found that at least some other cell cycle proteins containing nuclear export signals are resistant to LMP1. If LMP1 targets only a few proteins for export, it might be possible to develop drugs to limit EBV infection with few side effects. {blacksquare}



Nicole LeBrasseur

lebrasn{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5
Naoko Ohtani, Paul Brennan, Stefan Gaubatz, Elaine Sanij, Paul Hertzog, Ernst Wolvetang, Jacques Ghysdael, Martin Rowe, and Eiji Hara
J. Cell Biol. 2003 162: 173-183. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 793K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents